99 related articles for article (PubMed ID: 7482859)
1. Treatment of leukopenia with granulocyte-macrophage colony-stimulating factor after heart transplantation.
Wasler A; Iberer F; Auer T; Petutschnigg B; Müller H; Pfeifer J; Deutsch T; Tscheliessnigg KH
Transplant Proc; 1995 Oct; 27(5):2633-4. PubMed ID: 7482859
[No Abstract] [Full Text] [Related]
2. Granulocyte macrophage colony-stimulating factor for the therapy of cytomegalovirus and ganciclovir-induced leukopenia in a renal transplant recipient.
Kutsogiannis DJ; Crowther MA; Lazarovits AI
Transplantation; 1992 Apr; 53(4):930-2. PubMed ID: 1314441
[No Abstract] [Full Text] [Related]
3. Use of rHu GM-CSF in renal-transplant patients developing leukopenia.
Hashmi A; Hussain M; Hussain Z; Ahmed E; Shamsi T; Naqvi R; Ali B; Mehdi H; Mohsin R; Naqvi A; Rizvi A
Transplant Proc; 1997 Nov; 29(7):3053. PubMed ID: 9365663
[No Abstract] [Full Text] [Related]
4. Treatment of peripheral leukopenia after cadaveric kidney transplantation.
Xiwen B; Lixin Y; Junjie M
Transplant Proc; 1996 Jun; 28(3):1631-2. PubMed ID: 8658815
[No Abstract] [Full Text] [Related]
5. Nursing care of AIDS patients participating in a Phase I/II trial of recombinant human granulocyte-macrophage colony stimulating factor.
Lynch M; Yanes L; Todd K
Oncol Nurs Forum; 1988; 15(4):463-9. PubMed ID: 3041383
[No Abstract] [Full Text] [Related]
6. [Clinical study of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced leukopenia].
Shi YK; Sun Y; Su M
Zhonghua Zhong Liu Za Zhi; 1994 Sep; 16(5):356-9. PubMed ID: 7895587
[TBL] [Abstract][Full Text] [Related]
7. Use of granulocyte-macrophage colony-stimulating factor in leukopenic renal transplant recipients.
Page B; Morin MP; Mamzer MF; Thervet E; Legendre C
Transplant Proc; 1994 Feb; 26(1):283. PubMed ID: 8108982
[No Abstract] [Full Text] [Related]
8. Different response to recombinant human granulocyte-macrophage colony-stimulating factor in primary and secondary graft failure after bone marrow transplantation.
Sierra J; Terol MJ; Urbano-Ispizua A; Rovira M; Marin P; Carreras E; Batlle M; Rozman C
Exp Hematol; 1994 Jul; 22(7):566-72. PubMed ID: 8013572
[TBL] [Abstract][Full Text] [Related]
9. Prospective, randomized trial of sequential interleukin-3 and granulocyte- or granulocyte-macrophage colony-stimulating factor after standard-dose chemotherapy in cancer patients.
Palmeri S; Leonardi V; Danova M; Porta C; Ferrari S; Fincato G; Citarrella P
Haematologica; 1999 Nov; 84(11):1016-23. PubMed ID: 10553163
[TBL] [Abstract][Full Text] [Related]
10. MOPP/ABV/CAD chemotherapy with and without recombinant human granulocyte-macrophage colony stimulating factor in untreated, unfavorable prognosis Hodgkin's disease.
Riccardi A; Gobbi P; Danova M; Giordano M; Pieresca C; Bertoloni D; Brugnatelli S; Ascari E
Haematologica; 1993; 78(1):44-8. PubMed ID: 7684012
[TBL] [Abstract][Full Text] [Related]
11. The role of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in chemotherapy for lung cancer.
Saijo N; Eguchi K; Etou H; Miyachi S; Morinari H; Nakada K; Noda K; Ohkuni Y; Watanabe K; Yamada Y
Semin Oncol; 1994 Feb; 21(1 Suppl 1):54-8. PubMed ID: 7512277
[No Abstract] [Full Text] [Related]
12. Granulocyte colony-stimulating factor. A new application for cytomegalovirus-induced neutropenia in cardiac allograft recipients.
Patel HD; Anderson JR; Duncombe AS; Carrington D; Murday A
Transplantation; 1994 Oct; 58(7):863-7. PubMed ID: 7940727
[No Abstract] [Full Text] [Related]
13. The use of granulocyte colony-stimulating factor in the treatment of fever and neutropenia in a heart transplant patient.
Gordon MS; O'Donnell JA; Mohler ER; Cooper MA
J Heart Lung Transplant; 1993; 12(4):706-7. PubMed ID: 7690254
[TBL] [Abstract][Full Text] [Related]
14. Treatment with tumor necrosis factor-alpha and granulocyte-macrophage colony-stimulating factor increases epidermal Langerhans' cell numbers in cancer patients.
Janik JE; Miller LL; Kopp WC; Taub DD; Dawson H; Stevens D; Kostboth P; Curti BD; Conlon KC; Dunn BK; Donegan SE; Ullrich R; Alvord WG; Gause BL; Longo DL
Clin Immunol; 1999 Dec; 93(3):209-21. PubMed ID: 10600331
[TBL] [Abstract][Full Text] [Related]
15. Severe neutropenia after renal transplantation and its reversal with granulocyte colony-stimulating factor.
Birkeland SA; Elbirk A; Rohr N; Jørgensen KA
Transplant Proc; 1994 Dec; 26(6):3098-9. PubMed ID: 7527945
[No Abstract] [Full Text] [Related]
16. Colony-stimulating factor for treatment of leukopenia after kidney allografting.
Tajima A; Aso Y; Kawabe K; Suzuki K; Ohtawara Y; Ohta N; Hata M; Nakano M; Ushiyama T; Ueda D
Transplant Proc; 1991 Feb; 23(1 Pt 2):1369-70. PubMed ID: 1703338
[No Abstract] [Full Text] [Related]
17. [Clinical study of recombinant human granulocyte colony stimulating factor (rhG-CSF) on leukopenia induced by chemotherapy in cancer patients].
Shi YK; Zhou JC; Feng FY
Zhonghua Zhong Liu Za Zhi; 1994 May; 16(3):207-10. PubMed ID: 7525173
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-3 followed by GM-CSF for delayed engraftment after autologous bone marrow transplantation.
Crump M; Couture F; Kovacs M; Saragosa R; McCrae J; Brandwein J; Huebsch L; Beauregard-Zollinger L; Keating A
Exp Hematol; 1993 Mar; 21(3):405-410. PubMed ID: 8440338
[TBL] [Abstract][Full Text] [Related]
19. Granulocyte-macrophage colony-stimulating factor after autologous marrow transplantation for Hodgkin's disease.
Klingemann HG; Wilkie-Boyd K; Rubin A; Onetto N; Nantel SH; Barnett MJ; Reece DE; Shepherd JD; Phillips GL
Biotechnol Ther; 1994; 5(1-2):1-13. PubMed ID: 7703829
[TBL] [Abstract][Full Text] [Related]
20. Myelosuppressive changes from single or repeated doses of radioantibody therapy: effect of bone marrow transplantation, cytokines, and hematopoietic suppression.
Blumenthal RD; Alisauskas R; Lew W; Sharkey RM; Goldenberg DM
Exp Hematol; 1998 Aug; 26(9):859-68. PubMed ID: 9694507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
